Jun 19, 2025 / 08:00AM GMT
Christopher Hollowood - Syncona Ltd - Interim Chairman of the Board, Chief Executive Officer of Syncona Investment Management Limited
Welcome to Syncona's annual results. As you'll have seen, we've also put out a strategic update.
This is the outcome of a considerable amount of work with the Board and the similar team and done very much in conjunction with our shareholders. We're excited to tell you about both, as the results demonstrate the strength of our underlying business and the strategic update we believe is an elegant proposal that matches what we've heard from our shareholders about what they want.
We continue to show strong executional performance. The biotech markets are now in the fifth year of their downturn, and that has inevitably hit valuations. NAV per share is down 9.4% to 171p. Autolus has been the main driver. Autolus traded off significantly despite receiving market authorization and launching Quell in the US.
The private side is held up reasonably well with uplifts and Beacon and Forcefield netted off by partial write downs in Resolution and Biomodal. The
Full Year 2025 Syncona Ltd Earnings Call Transcript
Jun 19, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers